Top

The journal of nutrition, health & aging

Published in:

14-10-2023 | Sarcopenia | Original Research

Sarcopenia Screened with SARC-F and Subjective Memory Complaints Are Independently Associated with Increased Risk of Incident Dementia among Cognitively Unimpaired Older Adults

Authors: Chia-Lin Li, H.-Y. Chang, Y.-H. Tsai

Published in: The journal of nutrition, health & aging | Issue 11/2023

Abstract

Objectives

The main aim of this study was to examine the association of sarcopenia and subjective memory complaints with the incidence of dementia in a population-based cohort of cognitively unimpaired older adults.

Design

Three-year longitudinal study.

Settings and Participants

A total of 2163 community-dwelling persons aged 65 years or older who participated in the National Health Interview Survey in Taiwan, 2017.

Measurements

Sarcopenia was determined based on SARC-F, a self-reported symptom-based questionnaire that includes five components: strength, assistance walking, rise from a chair, climb stairs, and falls. Two questions (“Do you have difficulties with your memory or attention?” and “Do you have difficulties with your memory only or attention only or both?”) were used to screen for subjective memory complaints (SMCs). The incidence of dementia was determined by data linkage to the Taiwan National Health Insurance claims database from 2018 to 2020.

Results

Among the 2163 participants without dementia at baseline, 135 had incident dementia during the 3-year follow-up, giving a crude incidence rate of 6.2% (135/2163). Compared to participants free from sarcopenia and SMCs, the adjusted hazard ratio for incident dementia was 1.83 (95% confidence interval [CI]: 1.23–2.72) for SMCs alone, 2.40 (95% CI: 1.17–4.93) for sarcopenia alone, and 2.49 (95% CI: 1.21–5.11) for coexisting SMCs and sarcopenia.

Conclusions

Our results indicate that sarcopenia screened with SARC-F and SMCs independently predict the cognitively unimpaired older adults at risk of incident dementia. Our findings highlight the importance of screening not only for cognitive but also muscle deficits to identify those at increased risk of incident dementia.

Available only for authorised users

Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–450. doi:https://doi.org/10.1007/BF02982704CrossRefPubMedPubMedCentral

Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12:403–409. doi:https://doi.org/10.1016/j.jamda.2011.04.014CrossRefPubMedPubMedCentral

Bhasin S, Travison TG, Manini TM, et al. Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020;68:1410–1418. doi:https://doi.org/10.1111/jgs.16372CrossRefPubMed

Sayer AA, Cruz-Jentoft A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 2022;51:afac220. doi:https://doi.org/10.1093/ageing/afac220CrossRefPubMedPubMedCentral

Wu TY, Liaw CK, Chen FC, Kuo KL, Chie WC, Yang RS. Sarcopenia Screened With SARC-F Questionnaire Is Associated With Quality of Life and 4-Year Mortality. J Am Med Dir Assoc. 2016;17:1129–1135. doi:https://doi.org/10.1016/j.jamda.2016.07.029CrossRefPubMed

Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7:28–36. doi:https://doi.org/10.1002/jcsm.12048CrossRefPubMed

Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc. 2012;13:121–126. doi:https://doi.org/10.1016/j.jamda.2011.07.004CrossRefPubMed

Yang Y, Xiao M, Leng L, et al. A systematic review and meta-analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia. J Cachexia Sarcopenia Muscle. 2023;14:45–56. doi:https://doi.org/10.1002/jcsm.13143CrossRefPubMed

Minett TS, Dean JL, Firbank M, English P, O’Brien JT. Subjective memory complaints, white-matter lesions, depressive symptoms, and cognition in elderly patients. Am J Geriatr Psychiatry. 2005;13:665–671. doi:https://doi.org/10.1176/appi.ajgp.13.8.665CrossRefPubMed

10.

Scheef L, Spottke A, Daerr M, et al. Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology. 2012;79:1332–1339. doi:https://doi.org/10.1212/WNL.0b013e31826c1a8dCrossRefPubMed

11.

Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA. Memory complaints are related to Alzheimer disease pathology in older persons. Neurology. 2006;67:1581–1585. doi:https://doi.org/10.1212/01.wnl.0000242734.16663.09CrossRefPubMed

12.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology. 2001;57:2217–2222. doi:https://doi.org/10.1212/wnl.57.12.2217CrossRefPubMed

13.

Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010;67:414–422. doi:https://doi.org/10.1001/archgenpsychiatry.2010.30CrossRefPubMed

14.

Lin SM, Apolinário D, Vieira Gomes GC, et al. Association of Cognitive Performance with Frailty in Older Individuals with Cognitive Complaints. J Nutr Health Aging. 2022;26:89–95. doi:https://doi.org/10.1007/s12603-021-1712-5CrossRefPubMed

15.

Al-Sari UA, Tobias JH, Archer H, Clark EM. Do subjective memory complaints predict falls, fractures and healthcare utilization? A two-year prospective study based on a cohort of older women recruited from primary care. Int J Geriatr Psychiatry. 2017;32:968–976. doi:https://doi.org/10.1002/gps.4555CrossRefPubMed

16.

Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249–256. doi:https://doi.org/10.1016/j.jamda.2011.01.003CrossRefPubMed

17.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423. doi:https://doi.org/10.1093/ageing/afq034CrossRefPubMedPubMedCentral

18.

Wu IC, Lin CC, Hsiung CA, et al. Epidemiology of sarcopenia among community-dwelling older adults in Taiwan: a pooled analysis for a broader adoption of sarcopenia assessments. Geriatr Gerontol Int. 2014;14 Suppl 1:52–60. doi:https://doi.org/10.1111/ggi.12193CrossRefPubMed

19.

Li CL, Stanaway FF, Chang HY, Chen MC, Tsai YH. Joint predictability of physical frailty/pre-frailty and subjective memory complaints on mortality risk among cognitively unimpaired older adults. Eur J Ageing. 2023;20:17. doi:https://doi.org/10.1007/s10433-023-00765-yCrossRefPubMedPubMedCentral

20.

Montejo P, Montenegro M, Fernandez MA, Maestu F. Subjective memory complaints in the elderly: Prevalence and influence of temporal orientation, depression and quality of life in a population-based study in the city of Madrid. Aging Ment Health. 2011;15:85–96. doi:https://doi.org/10.1080/13607863.2010.501062CrossRefPubMed

21.

Li CL, Chang HY, Shyu YL, Stanaway FF. Relative role of physical frailty and poor cognitive performance in progression to dementia. J Am Med Dir Assoc. 2021;22:1558–1559. doi:https://doi.org/10.1016/j.jamda.2021.02.022CrossRefPubMed

22.

Shih YH, Chang HY, Lu MI, Hurng BS. Time trend of prevalence of self-reported cataract and its association with prolonged sitting in Taiwan from 2001 and 2013. BMC Ophthalmol. 2014;14:128. doi:https://doi.org/10.1186/1471-2415-14-128CrossRefPubMedPubMedCentral

23.

Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: https://doi.org/10.1016/0022-3956(75)90026-6CrossRefPubMed

24.

Katzman R, Zhang MY, Qu OY, et al. A Chinese version of the mini-mental state examination: impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol. 1988;41:971–978. doi: https://doi.org/10.1016/0895-4356(88)90034-0CrossRefPubMed

25.

Cao L, Chen S, Zou C, et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging. 2014;18:277–283. doi:https://doi.org/10.1007/s12603-013-0410-3CrossRefPubMed

26.

Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia?. J Am Med Dir Assoc. 2014;15:630–634. doi:https://doi.org/10.1016/j.jamda.2014.04.021CrossRefPubMed

27.

Radloff L. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. doi:https://doi.org/10.1177/014662167700100306CrossRef

28.

Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10:77–84.CrossRefPubMed

29.

Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509. doi:https://doi.org/10.2307/2670170CrossRef

30.

Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multistate models. Stat Med. 2007;26:2389–2430. doi: https://doi.org/10.1002/sim.2712CrossRefPubMed

31.

Beeri MS, Leugrans SE, Delbono O, Bennett DA, Buchman AS. Sarcopenia is associated with incident Alzheimer’s dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021;69:1826–1835. doi:https://doi.org/10.1111/jgs.17206CrossRefPubMedPubMedCentral

32.

Waldorff FB, Siersma V, Vogel A, Waldemar G. Subjective memory complaints in general practice predicts future dementia: a 4-year follow-up study. Int J Geriatr Psychiatry. 2012;27:1180–1188. doi:https://doi.org/10.1002/gps.3765CrossRefPubMed

33.

Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130:439–451. doi: 10.1111/acps.1233.CrossRefPubMed

34.

Kim HJ, Chung JH, Eun Y, Kim SH. Cortical Thickness and White Matter Hyperintensity Changes Are Associated With Sarcopenia in the Cognitively Normal Older Adults. Psychiatry Investig. 2023;20:581. doi:https://doi.org/10.30773/pi.2022.0200eCrossRefPubMedPubMedCentral

35.

Cesari M, Vellas B. Sarcopenia: a novel clinical condition or still a matter for research? J Am Med Dir Assoc. 2012;13:766–767. doi:https://doi.org/10.1016/j.jamda.2012.07.020CrossRefPubMed

36.

Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc. 2010;11(6):391–396. doi:https://doi.org/10.1016/j.jamda.2010.04.014CrossRefPubMedPubMedCentral

Title: Sarcopenia Screened with SARC-F and Subjective Memory Complaints Are Independently Associated with Increased Risk of Incident Dementia among Cognitively Unimpaired Older Adults
Authors: Chia-Lin Li
H.-Y. Chang
Y.-H. Tsai
Publication date: 14-10-2023
Publisher: Springer Paris
Keywords: Sarcopenia
Dementia
Dementia
Published in: The journal of nutrition, health & aging / Issue 11/2023
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-023-2006-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Design

Settings and Participants

Measurements

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2023

Aging, Body Composition, and Cognitive Decline: Shared and Unique Characteristics

Comparative Analysis of Intrinsic Capacity Impairments, Determinants, and Clinical Consequences in Older Community-Dwellers in Japan and Taiwan: Longitudinal Studies Showing Shared Traits and Distinct Presentations

Cost-Consequences Analysis Following Different Exercise Interventions in Institutionalized Oldest Old: A Pilot Study of a Randomized Clinical Trial

Association between Dried Fruit Intake and DNA Methylation: A Multivariable Mendelian Randomization Analysis

Body Composition, Physical Function, and Dietary Patterns in People from 20 to Over 80 Years Old

Eating assessment tool (EAT-10) Has Been Validated as a Screening Tool for Dysphagia, Not for Oropharingeal Dysphagia

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials